Orchard Therapeutics PLC Probability of Future Stock Price Finishing Over 5.27
| ORTXDelisted Stock | USD 5.27 0.01 0.19% |
Orchard |
Orchard Therapeutics Target Price Odds to finish over 5.27
The tendency of Orchard Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.27 | 90 days | 5.27 | about 26.92 |
Based on a normal probability distribution, the odds of Orchard Therapeutics to move above the current price in 90 days from now is about 26.92 (This Orchard Therapeutics PLC probability density function shows the probability of Orchard Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Orchard Therapeutics PLC has a beta of -1.09. This indicates Additionally Orchard Therapeutics PLC has an alpha of 0.2865, implying that it can generate a 0.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Orchard Therapeutics Price Density |
| Price |
Predictive Modules for Orchard Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Orchard Therapeutics PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Orchard Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Orchard Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Orchard Therapeutics is not an exception. The market had few large corrections towards the Orchard Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Orchard Therapeutics PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Orchard Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | -1.09 | |
σ | Overall volatility | 0.26 | |
Ir | Information ratio | 0 |
Orchard Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orchard Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orchard Therapeutics PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orchard Therapeutics is not yet fully synchronised with the market data | |
| Orchard Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 21.84 M. Net Loss for the year was (72.92 M) with loss before overhead, payroll, taxes, and interest of (76.52 M). | |
| Orchard Therapeutics PLC currently holds about 170.89 M in cash with (93.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.35. | |
| Over 88.0% of the company shares are owned by institutional investors |
Orchard Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orchard Stock often depends not only on the future outlook of the current and potential Orchard Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orchard Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.8 M | |
| Cash And Short Term Investments | 143.8 M |
Orchard Therapeutics Technical Analysis
Orchard Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Orchard Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orchard Therapeutics PLC. In general, you should focus on analyzing Orchard Stock price patterns and their correlations with different microeconomic environments and drivers.
Orchard Therapeutics Predictive Forecast Models
Orchard Therapeutics' time-series forecasting models is one of many Orchard Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orchard Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Orchard Therapeutics PLC
Checking the ongoing alerts about Orchard Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orchard Therapeutics PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orchard Therapeutics is not yet fully synchronised with the market data | |
| Orchard Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 21.84 M. Net Loss for the year was (72.92 M) with loss before overhead, payroll, taxes, and interest of (76.52 M). | |
| Orchard Therapeutics PLC currently holds about 170.89 M in cash with (93.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.35. | |
| Over 88.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Orchard Stock
If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |